Pharmacotherapy for Complex Substance Use Disorders
A Practical Guide
In 2020, the National Survey on Drug Use and Health estimated that 40.3 million Americans met the criteria for a substance use disorder (SUD) in the past year. Yet few FDA-approved treatments exist for SUDs—and no explicit treatment guidelines. When it comes to multi-SUDs in particular, the dearth of literature is notable.
This is where Pharmacotherapy for Complex Substance Use Disorders: A Practical Guide comes in. Fifteen addiction psychiatrists have contributed to this volume, bringing their clinical experience to bear for readers that include mental health and primary care clinicians.
Introductory chapters provide a necessary framework, offering an overview of SUDs; general guidelines for taking a history, making a medical and a psychiatric evaluation, and forming a diagnosis; and a discussion of the neurobiology of addiction.
In the subsequent chapters, the volume delves into maintenance pharmacological treatment for co-occurring substances that include
- Novel psychoactive substances
Uniquely, this guide also discusses psychopharmacological approaches to working with special patient populations—adolescents, LGBTQ+ individuals, and pregnant people among them.
Filled with tables for ease of reference both when diagnosing and treating patients, and bolstered by evidence-based, actionable information, Pharmacotherapy for Complex Substance Use Disorders: A Practical Guide sets itself apart as an indispensable resource for all providers aiding individuals on their journeys of recovery.
- Author Contribution
- Chapter 1. Overview of Substance Use Disorders
- Chapter 2. General Approach to Patients with Multi-substance Use Disorders
- Chapter 3. The Neurobiology of Addiction and Principles of Pharmacology
- Chapter 4. Laboratory Testing
- Chapter 5. Alcohol and Co-Occurring Substance Use
- Chapter 6. Stimulants and Co-Occurring Substance Use
- Chapter 7. Opiods and Co-Occuring Substance
- Chapter 8. Trinity Combinations
- Chapter 9. Novel Psychoactive Substances
- Chapter 10. Co-Occuring and Substance Use Disorders
- Chapter 11. HIV and Substance Use Disorders
- Chapter 12. Substance Use Disorders in Pregnancy
- Chapter 13. Adolescents With Substance Use Disorders
- Chapter 14. Substance Use Disorders in the LGBTQ Population
- Chapter 15. Pain and Sbstance Abuse Disorders
- Tabark Altai, M.D.
M. Asif Khan, M.D., M.R.O.
Britney Lambert, M.D.
Benjamin Li, M.D.
Claire K. Morice, M.D.
Nidal Moukaddam, M.D., Ph.D.
Crystal Obiozor, M.D.
Andres Ojeda, M.D.
Edore Onigu-Otite, M.D.
Hazem Shahin, M.D.
Nancy C. Shenoi, M.D.
Daryl Shorter, M.D.
Thanh Thuy Truong, M.D.
Richa Vijayvargiya, M.D.
Mark Yurewicz, M.D.
About the Authors
Thanh Thuy Truong, M.D., is Assistant Professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine, Houston, Texas.
Benjamin T. Li, M.D., is Associate Professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine, Houston, Texas.
Daryl Shorter, M.D., is Medical Director of Addiction Services at The Menninger Clinic, and Associate Professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine in Houston, Texas.
Nidal Moukaddam, M.D., Ph.D., is Associate Professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine in Houston, Texas.
Thomas R. Kosten, M.D., is Jay H. Waggoner Endowed Chair, Director of the Division of Alcohol and Addiction Psychiatry, and Professor of Psychiatry, Neuroscience, Pharmacology, and Immunology and Rheumatology at the Baylor College of Medicine in Houston, Texas.
Carousel Control - items will scroll by tabbing through them, otherwise arrows can be used to scroll one item at a time